目录产品 » SARS-CoV-2 Nucleocapsid Antibody (N22HC)

SARS-CoV-2 Nucleocapsid Antibody (N22HC)

SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that cause illness ranging from the common cold to severe diseases. SARS-CoV-2 Nucleocapsid Protein is derived from SARS-CoV-2, which is associated with nucleic acid. It is a most abundant protein of coronavirus. Because of strong immunogenicity of coronavirus Nucleocapsid, it was believed that SARS-CoV-2 Nucleocapsid protein has potential value for the diagnosis of the virus.
询价
V80101-0.1

咨询产品问题
Specificity SARS-CoV-2 Nucleocapsid
Clone ID N22HC
Isotype Recombinant human IgG1
返回

Purification Affinity chromatography
Concentration ≥ 2mg/ml
Formulation PBS, pH 7.4, containing 0.03% Proclin 300
Storage For long term storage, aliquot and store at -25°C~-15°C or below. Avoid repeated freezing and thawing cycles.
Note GenScript can customize this product per customer's request including product size, buffer components, etc.
返回

ELISA
返回

SARS-CoV-2 Nucleocapsid Antibody (N22HC)

»

<
>

Target Background SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that cause illness ranging from the common cold to severe diseases. SARS-CoV-2 Nucleocapsid Protein is derived from SARS-CoV-2, which is associated with nucleic acid. It is a most abundant protein of coronavirus. Because of strong immunogenicity of coronavirus Nucleocapsid, it was believed that SARS-CoV-2 Nucleocapsid protein has potential value for the diagnosis of the virus.
返回

有限使用许可与使用限制 This Product is provided under a limited, non-exclusive, non-transferable, and non-sublicensable end-user license strictly limited to the permitted uses set forth in GenScript’s official documentation, quotations, or written agreements. Any use beyond such scope requires GenScript’s prior written authorization or license.
Except as expressly authorized in writing by GenScript, Customer shall not, and shall not permit, procure, enable, or assist any third party to: (a) commercialize or otherwise exploit the Product, including by reselling, distributing, transferring, sublicensing, or otherwise making the Product (including any product incorporating the Product) available to any third party; (b) copy, reproduce, clone, reverse clone, sequence, analyze, characterize, deconstruct, reconstruct, reverse engineer, or otherwise attempt to discover the composition, sequence, structure, binding characteristics, epitope recognition characteristics, or other proprietary features of the Product; (c) modify, derivatize, humanize, optimize, mutate, design around, or generate any variants, derivatives, fragments, substitutes, or functional equivalents of the Product; or (d) use the Product, any information derived therefrom, or any computational, AI-enabled, or sequence-based design method to develop, manufacture, offer for sale, sell, or commercialize any product or service competitive with the Product or GenScript’s products or services.
All intellectual property rights and all rights not expressly granted herein are reserved by GenScript. No rights are granted by implication, estoppel, or otherwise.
返回

For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.